Immune Thrombocytopenic Purpura in Patients with COVID-19
We described three COVID-19-infected patients with profound immune thrombocytopenia causing haemorrhagic mucocutaneous complications. We conclude that an immune mechanism was responsible as common causes were excluded. Since corticoids were considered harmful in the circumstances, the patients were...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SMC MEDIA SRL
2020-06-01
|
| Series: | European Journal of Case Reports in Internal Medicine |
| Subjects: | |
| Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/1751 |
| _version_ | 1818541972123549696 |
|---|---|
| author | Sabine Revuz Nathalie Vernier Leilah Saadi Julien Campagne Sophie Poussing François Maurier |
| author_facet | Sabine Revuz Nathalie Vernier Leilah Saadi Julien Campagne Sophie Poussing François Maurier |
| author_sort | Sabine Revuz |
| collection | DOAJ |
| description | We described three COVID-19-infected patients with profound immune thrombocytopenia causing haemorrhagic mucocutaneous complications. We conclude that an immune mechanism was responsible as common causes were excluded. Since corticoids were considered harmful in the circumstances, the patients were successfully treated with intravenous immunoglobulins without later relapse. |
| first_indexed | 2024-12-11T22:16:05Z |
| format | Article |
| id | doaj.art-25e5d3bb556a41a0bafaaff935272c27 |
| institution | Directory Open Access Journal |
| issn | 2284-2594 |
| language | English |
| last_indexed | 2024-12-11T22:16:05Z |
| publishDate | 2020-06-01 |
| publisher | SMC MEDIA SRL |
| record_format | Article |
| series | European Journal of Case Reports in Internal Medicine |
| spelling | doaj.art-25e5d3bb556a41a0bafaaff935272c272022-12-22T00:48:35ZengSMC MEDIA SRLEuropean Journal of Case Reports in Internal Medicine2284-25942020-06-0110.12890/2020_0017511382Immune Thrombocytopenic Purpura in Patients with COVID-19Sabine Revuz0Nathalie Vernier1Leilah Saadi2Julien Campagne3Sophie Poussing4François Maurier5Hôpitaux Privés de Metz, Metz, FranceHôpitaux Privés de Metz, Metz, FranceHôpitaux Privés de Metz, Metz, FranceHôpitaux Privés de Metz, Metz, FranceHôpitaux Privés de Metz, Metz, FranceHôpitaux Privés de Metz, Metz, FranceWe described three COVID-19-infected patients with profound immune thrombocytopenia causing haemorrhagic mucocutaneous complications. We conclude that an immune mechanism was responsible as common causes were excluded. Since corticoids were considered harmful in the circumstances, the patients were successfully treated with intravenous immunoglobulins without later relapse.https://www.ejcrim.com/index.php/EJCRIM/article/view/1751covid-19sars-cov-2thrombocytopeniaintravenous immunoglobulins |
| spellingShingle | Sabine Revuz Nathalie Vernier Leilah Saadi Julien Campagne Sophie Poussing François Maurier Immune Thrombocytopenic Purpura in Patients with COVID-19 European Journal of Case Reports in Internal Medicine covid-19 sars-cov-2 thrombocytopenia intravenous immunoglobulins |
| title | Immune Thrombocytopenic Purpura in Patients with COVID-19 |
| title_full | Immune Thrombocytopenic Purpura in Patients with COVID-19 |
| title_fullStr | Immune Thrombocytopenic Purpura in Patients with COVID-19 |
| title_full_unstemmed | Immune Thrombocytopenic Purpura in Patients with COVID-19 |
| title_short | Immune Thrombocytopenic Purpura in Patients with COVID-19 |
| title_sort | immune thrombocytopenic purpura in patients with covid 19 |
| topic | covid-19 sars-cov-2 thrombocytopenia intravenous immunoglobulins |
| url | https://www.ejcrim.com/index.php/EJCRIM/article/view/1751 |
| work_keys_str_mv | AT sabinerevuz immunethrombocytopenicpurpurainpatientswithcovid19 AT nathalievernier immunethrombocytopenicpurpurainpatientswithcovid19 AT leilahsaadi immunethrombocytopenicpurpurainpatientswithcovid19 AT juliencampagne immunethrombocytopenicpurpurainpatientswithcovid19 AT sophiepoussing immunethrombocytopenicpurpurainpatientswithcovid19 AT francoismaurier immunethrombocytopenicpurpurainpatientswithcovid19 |